Search Results 1581-1590 of 13610 for Birth Control Evolution

  1. A Study to Investigate FE 999049 in the Treatment of Infertility in Women Aged 18-34 Years Old with Assisted Reproductive Technology - Mayo Clinic

    Any known endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney) with the exception of pharmacologically controlled sub-clinical ...

  2. CARDIOVASCULAR UPDATE

    68. • TAVI results in better survival com- pared with medical management in high-risk patients with severe aortic stenosis. • The risk of major stroke is higher.

  3. Thomas A. Billings, D.O. - Doctors and Medical Staff - Mayo Clinic

    1999 - present. LeaderChronic Disease Management Team, Kasson Mayo Family Practice Clinic, Department of Family Medicine. 1999 - present. PreceptorFamily ...

  4. Publications - Ruth E. DeFoster, M.D. - Mayo Clinic

    ... Controlled Trial. JMIR Res Protoc. 2025 Feb 26; 14:e57264. View PubMed; Fredrick TW, DeFoster RE. 66-Year-Old Woman With Fatigue and Hypotension. Mayo Clin ...

  5. Publications - Dennis W. Regan, M.D. - Mayo Clinic

    Preoperative Management of Gastrointestinal and Pulmonary Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.

  6. Publications - Zach J. Fleissner, D.O. - Mayo Clinic

    Belfiore J, Castellani Niccolini N, Fleissner Z, Chadha R, Biancofiore G. Pain management in liver transplant recipients: a focus on current and future ...

  7. Publications - William C. Mundell, M.D. - Mayo Clinic

    Implementation guide to improve accuracy and efficiency for outpatient referrals using EHR functionality Management in Healthcare. 2022. Warner MA ...

  8. Publications - Jesse J. Muir, M.D. - Mayo Clinic

    Devine RM, van Heerden JA, Grant CS, Muir JJ. The role of methylene blue infusion in the management of persistent or recurrent hyperparathyroidism. Surgery.

  9. A Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma - Mayo Clinic

    - A woman of childbearing potential (WOCBP) must agree to use highly effective contraception during study participation and 30 days after the completion of ...

  10. A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared with Placebo for the Treatment of Participants with Mycobacterium Avium Complex (MAC) Pulmonary Disease - Mayo Clinic

    Also, the pharmacokinetic (PK) of SPR719, active moiety, following orally (po) administered prodrug SPR720 in a participant population with NTM-PD.